CHAPTER 1: THE MANAGEMENT OF ERECTILE DYSFUNCTION: AN AUA UPDATE

Abstract

No AccessJournal of UrologyAdult Urology: Sexual Function/Infertility1 Jul 2005CHAPTER 1: THE MANAGEMENT OF ERECTILE DYSFUNCTION: AN AUA UPDATE DROGO K. MONTAGUE, JONATHAN P. JAROW, GREGORY A. BRODERICK, ROGER R. DMOCHOWSKI, JEREMY P.W. HEATON, TOM F. LUE, AARON J. MILBANK, AJAY NEHRA, IRA D. SHARLIP, and (MEMBERS OF THE ERECTILE DYSFUNCTION GUIDELINE UPDATE PANEL) DROGO K. MONTAGUEDROGO K. MONTAGUE Financial interest and/or other relationship with AMS, Bayer, Pfizer and Lilly-ICOS. More articles by this author , JONATHAN P. JAROWJONATHAN P. JAROW Financial interest and/or other relationship with Bayer, Pfizer Canada and Lilly. More articles by this author , GREGORY A. BRODERICKGREGORY A. BRODERICK Financial interest and/or other relationship with Johnson & Johnson, Bayer, Eli Lilly, Pfizer and GlaxcoSmithKline. More articles by this author , ROGER R. DMOCHOWSKIROGER R. DMOCHOWSKI Financial interest and/or other relationship with Indevus and Watson Pharmaceuticals. More articles by this author , JEREMY P.W. HEATONJEREMY P.W. HEATON Financial interest and/or other relationship with MSM, Pfizer, Cellegy. More articles by this author , TOM F. LUETOM F. LUE Financial interest and/or other relationship with Genix, Pfizer, Bayer-GSK, NexMed and Tap. More articles by this author , AARON J. MILBANKAARON J. MILBANK More articles by this author , AJAY NEHRAAJAY NEHRA More articles by this author , IRA D. SHARLIPIRA D. SHARLIP Financial interest and/or other relationship with Pfizer, Bayer-GSK, Lilly-ICOS, Johnson & Johnson and Sanofi. More articles by this author , and (MEMBERS OF THE ERECTILE DYSFUNCTION GUIDELINE UPDATE PANEL) More articles by this author View All Author Informationhttps://doi.org/10.1097/01.ju.0000164463.19239.19AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1 : The American Urological Association Erectile Dysfunction Clinical Guidelines Panel Report on The Treatment of Organic Erectile Dysfunction. Baltimore, MD: American Urological Association1996. Google Scholar 2 : NIH Consensus Statement1992; 10: 1. Google Scholar 3 : The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology1997; 49: 822. Google Scholar 4 : The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res2002; 14: 226. Google Scholar 5 : Prostate-Specific Antigen Best Practice Policy. Oncology2000; 14: 267. Google Scholar 6 World Health Organization: Second International Consultation on Erectile and Sexual Dysfunction. Paris, France, June 2003 Google Scholar 7 : Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol2000; 163: 460. Link, Google Scholar 8 : Sexual function in men older than 50 years of age: results from the health professionals’ follow-up study. Ann Intern Med2003; 139: 161. Google Scholar 9 : Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion1996. Google Scholar 10 : Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA2004; 291: 2978. Google Scholar 11 : Modifiable risk factors and erectile dysfunction: can lifestyle change modify risk?. Urology2000; 56: 302. Google Scholar 12 : Erectile dysfunction in the cardiac patient: how common and should we treat?. J Urol2003; 170: S46. Abstract, Google Scholar 13 : Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol1994; 151: 54. Abstract, Google Scholar 14 : Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol2000; 86: 175. Google Scholar 15 : Triggering of cardiac events by sexual activity: findings from a case-crossover analysis. Am J Cardiol2000; 86: 14F. Google Scholar 16 Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Circulation2002; 106: 3143. Google Scholar 17 : A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction. Br J Urol2001; 87: 75. Google Scholar 18 : Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry2001; 158: 1623. Google Scholar 19 : Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia2001; 44: 1296. Google Scholar 20 : Vardenafil Study Group. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res2001; 13: 192. Google Scholar 21 : On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. IC351 On-Demand Dosing Study Group. Int J Impot Res2001; 18: 2. Google Scholar 22 : Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med2002; 24: 1349. Google Scholar 23 : VA Technology Assessment Program Report No. 11: Treatment options for male erectile dysfunction, a systemic review of published studies of effectiveness. Boston, Massachusetts: VA Technology Assessment ProgramJanuary 1999. Google Scholar 24 : The multinational men’s attitudes to life events and sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin2004; 20: 607. Google Scholar 25 : Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol2003; 42: 1855. Google Scholar 26 : Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. Circulation1999; 99: 168. Google Scholar 27 : Cardiovascular effects of tadalafil. Am J Cardiol2003; 92: 37M. Google Scholar 28 : Oral pharmacotherapy and the contemporary evaluation and management of erectile dysfunction. Urology2003; 5: S9. Google Scholar 29 : Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology2002; 60: 28. Google Scholar 30 : Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol2004; 172: 658. Link, Google Scholar 31 : Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med1997; 336: 1. Google Scholar 32 : Disappointing results with transurethral alprostadil for erectile dysfunction in a urology practice setting. J Urol1998; 160: 2041. Link, Google Scholar 33 : Analysis of the consistency of intraurethral prostaglandin E(1) (MUSE) during at-home use. Urology2001; 58: 262. Google Scholar 34 : Rationale for combination therapy of intraurethral prostaglandin E1 and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res2002; 14: S38. Google Scholar 35 : Results from different patient populations using combined therapy with alprostadil and sildenafil: predictors of satisfaction. Br J Urol2000; 86: 469. Google Scholar 36 : Trazodone for erectile dysfunction: a systematic review and meta-analysis. Br J Urol2003; 92: 441. Google Scholar 37 : Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psychiatry1984; 145: 146. Google Scholar 38 : Drugs That Inhibit Adrenergic Nerves and Block Adrenergic Receptors. New York: Macmillan Company1985. Google Scholar 39 : Enhancement of sexual motivation in male rats by yohimbine. Science1984; 225: 847. Google Scholar 40 : Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Eur Urol2002; 41: 608. Google Scholar 41 : Dietary supplements and other alternative medicines for erectile dysfunction. What do I tell my patients?. Urol Clin North Am2002; 29: 11. vii. Google Scholar 42 : A double-blind crossover study evaluating the efficacy of Korean red ginseng in patients with erectile dysfunction: a preliminary report. J Urol2002; 168: 2070. Abstract, Google Scholar 43 : Obtaining herbal remedies for erectile dysfunction from the Internet is a potentially dangerous sexual practice (abstract). J Urol2004; 171: 314. Link, Google Scholar 44 : Evidence for pharmacological contamination of herbal erectile function products with type 5 phosphodiesterase (PDE5) inhibitors (abstract). J Urol2004; 171: 314. Link, Google Scholar 45 : Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol2004; 171: 1611. Link, Google Scholar 46 : The hydrophilic-coated penile prosthesis: 1-year experience. J Sex Med2004; 1: 221. Google Scholar 47 : The mentor Alpha 1 penile prosthesis with reservoir lock-out valve: effective prevention of auto-inflation with improved capability for ectopic reservoir placement. J Urol2002; 168: 1475. Link, Google Scholar 48 : Utility of magnetic resonance imaging in evaluating inflatable penile prosthesis malfunction and complaints. Int J Impot Res2003; 15: S155. Google Scholar 49 : MR imaging and biomedical implants, materials, and devices: an updated review. Radiology1991; 180: 541. Google Scholar 50 : Quantifying risks of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol1998; 159: 1537. Link, Google Scholar 51 : Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. J Urol1992; 147: 386. Link, Google Scholar 52 : Antibiotic prophylaxis in clean surgery: breast surgery and hernia repair. J Chemother2001; 13: 108. Google Scholar 53 : Preoperative vancomycin prophylaxis decreases incidence of postoperative hemodialysis vascular access infections. Am J Kidney Dis1997; 30: 343. Google Scholar 54 : Prophylactic cefazolin versus placebo in total hip replacement: report of a multicentre double-blind randomised trial. Lancet1981; 11: 795. Google Scholar 55 : Penile prosthesis surgery with the patient under local regional anesthesia. J Urol1993; 150: 1179. Google Scholar 56 : Penile prosthetic surgery under local anesthesia. J Urol1982; 28: 1190. Google Scholar © 2005 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byNangia A (2018) Testosterone Replacement Should be Given to Men with Erectile DysfunctionJournal of Urology, VOL. 197, NO. 2, (285-286), Online publication date: 1-Feb-2017.Gross M, Phillips E, Balen A, Eid J, Yang C, Simon R, Martinez D, Carrion R, Perito P, Levine L, Greenfield J and Munarriz R (2018) The Malleable Implant Salvage Technique: Infection Outcomes after Mulcahy Salvage Procedure and Replacement of Infected Inflatable Penile Prosthesis with Malleable ProsthesisJournal of Urology, VOL. 195, NO. 3, (694-698), Online publication date: 1-Mar-2016.Hellstrom W, Kaminetsky J, Belkoff L, Goldstein I, Tursi J, Uy J, Peterson C, Bowden C and Day W (2018) Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled StudyJournal of Urology, VOL. 194, NO. 2, (485-492), Online publication date: 1-Aug-2015.Roghmann F, Becker A, Sammon J, Ouerghi M, Sun M, Sukumar S, Djahangirian O, Zorn K, Ghani K, Gandaglia G, Menon M, Karakiewicz P, Noldus J and Trinh Q (2018) Incidence of Priapism in Emergency Departments in the United StatesJournal of Urology, VOL. 190, NO. 4, (1275-1280), Online publication date: 1-Oct-2013.Burnett A (2018) Erectile DysfunctionJournal of Urology, VOL. 175, NO. 3S, (S25-S31), Online publication date: 1-Mar-2006. Volume 174Issue 1July 2005Page: 230-239 Advertisement Copyright & Permissions© 2005 by American Urological Association, Inc.MetricsAuthor Information DROGO K. MONTAGUE Financial interest and/or other relationship with AMS, Bayer, Pfizer and Lilly-ICOS. More articles by this author JONATHAN P. JAROW Financial interest and/or other relationship with Bayer, Pfizer Canada and Lilly. More articles by this author GREGORY A. BRODERICK Financial interest and/or other relationship with Johnson & Johnson, Bayer, Eli Lilly, Pfizer and GlaxcoSmithKline. More articles by this author ROGER R. DMOCHOWSKI Financial interest and/or other relationship with Indevus and Watson Pharmaceuticals. More articles by this author JEREMY P.W. HEATON Financial interest and/or other relationship with MSM, Pfizer, Cellegy. More articles by this author TOM F. LUE Financial interest and/or other relationship with Genix, Pfizer, Bayer-GSK, NexMed and Tap. More articles by this author AARON J. MILBANK More articles by this author AJAY NEHRA More articles by this author IRA D. SHARLIP Financial interest and/or other relationship with Pfizer, Bayer-GSK, Lilly-ICOS, Johnson & Johnson and Sanofi. More articles by this author (MEMBERS OF THE ERECTILE DYSFUNCTION GUIDELINE UPDATE PANEL) More articles by this author Expand All Advertisement PDF downloadLoading ...